Skip to main content
CARE
NASDAQ Finance

Carter Bankshares Resolves Major Nonperforming Loan, Reports Soaring Q1 EPS Driven by $80M Gain

Analysis by Wiseek.ai
Sentiment info
Positive
Importance info
9
Price
$24.5
Mkt Cap
$540.039M
52W Low
$14.85
52W High
$24.91
Market data snapshot near publication time

summarizeSummary

Carter Bankshares, Inc. announced significantly improved first-quarter 2026 financial results, driven by the successful sale of a major nonperforming loan portfolio, which generated an $80 million gain and substantially boosted EPS and capital ratios.


check_boxKey Events

  • Record Q1 Earnings

    Reported net income of $85.8 million and diluted EPS of $3.88 for Q1 2026, a substantial increase from $8.5 million and $0.38 in Q4 2025.

  • Major Nonperforming Loan Resolution

    Completed the sale of a $209.5 million nonperforming loan portfolio for $289.5 million in cash on March 26, 2026.

  • Significant Financial Gain

    Recognized an $80.0 million net gain from the NPL transaction, comprised of a $65.0 million gain and a $15.0 million net recovery.

  • Balance Sheet De-risking

    Nonperforming loans decreased significantly by $220.0 million to $24.0 million, improving the NPL ratio from 6.29% to 0.64% of total portfolio loans.


auto_awesomeAnalysis

This filing reports a transformative quarter for Carter Bankshares, primarily due to the successful resolution and sale of a long-standing, large nonperforming loan portfolio. The transaction generated an $80 million net gain, leading to a massive increase in diluted EPS to $3.88 from $0.38 in the prior quarter, and a $3.49 per share increase in tangible book value. Critically, nonperforming loans plummeted from 6.29% to 0.64% of total loans, significantly de-risking the balance sheet and improving asset quality metrics. This resolution strengthens the company's financial foundation, enhances capital levels, and removes a major overhang, positioning the bank for more stable future growth. This positive news comes as the stock trades near its 52-week high, potentially reinforcing investor confidence. Investors should view this as a significant positive development, clearing the path for improved operational focus.

At the time of this filing, CARE was trading at $24.50 on NASDAQ in the Finance sector, with a market capitalization of approximately $540M. The 52-week trading range was $14.85 to $24.91. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed CARE - Latest Insights

CARE
Apr 23, 2026, 8:16 AM EDT
Filing Type: 8-K
Importance Score:
8
CARE
Apr 23, 2026, 8:15 AM EDT
Filing Type: 8-K
Importance Score:
9
CARE
Mar 26, 2026, 2:15 PM EDT
Filing Type: 8-K
Importance Score:
9
CARE
Mar 05, 2026, 12:53 PM EST
Filing Type: 10-K
Importance Score:
8
CARE
Feb 02, 2026, 8:16 AM EST
Filing Type: 8-K
Importance Score:
8
CARE
Jan 29, 2026, 8:16 AM EST
Filing Type: 8-K
Importance Score:
8